Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Assessing and Improving the Palatability of Pharmaceuticals

March 15, 2015

Taste may be subjective, but it is crucial to patient compliance, particularly for pediatric treatments.

Analytical Techniques for Oral Solid Dosage Formulation

March 15, 2015

Analytical technologies must accurately identify and measure the critical material attributes of APIs and excipients.

Simplify Formulation With PAT

March 15, 2015

PAT has aided formulation, both pre-and post-filing, by reducing costs and time frames.

Boosting Solubility in Lipid-Based Formulations

March 15, 2015

Ionic liquid technologies offer a new way to improve bioavailability.

Using Polymers for More Efficient Hot-Melt Extrusion and Spray Drying

March 15, 2015

New cellulosic polymers have been shown to improve solubility in these key amorphous solid dispersion processes.

BIO Encourages Transparency with Support of Biologic Interchangeability Bill

March 13, 2015

BIO and the Colorado BioScience Association urge Colorado Governor Hickenlooper to sign a bill that will help patients gain access to interchangeable biologic products following FDA approvals.

Drug Spending Highest Since 2003, Says Report

March 11, 2015

Drug spending rose last year at the highest rate since 2003, driven by specialty medicines, according to a report from pharmacy benefit manager Express Scripts.

Mallinckrodt Accents Critical Care With Ikaria Acquisition

March 06, 2015

Mallinckrodt Pharmaceuticals has bought Ikaria, a privately-held critical care company, for $2.3 billion.

WHO to Launch Ebola Vaccine Efficacy Trial March 7

March 06, 2015

The agency will employ a ring vaccination method similar to the one used to eradicate smallpox.

FDA Approves First Biosimilar

March 06, 2015

In a landmark decision, FDA approved Zarxio, making it the first biosimilar product in the United States.